Otriven Gegen Schnupfen Für Kinder Von 2 Bis 12 Jahren (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Otriven Gegen Schnupfen Für Kinder Von 2 Bis 12 Jahren, is a nasal decongestant presented as a solution for intranasal use. It relieves nasal congestion associated with colds, allergies and sinus irritation in children aged 2‑12 years.

GNH USA supplies Otriven Gegen Schnupfen Für Kinder Von 2 Bis 12 Jahren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline nasal spray acts on the nasal mucosa to reduce swelling and improve airflow. It is indicated for: - Common cold: alleviates nasal congestion in children. - Allergic rhinitis: reduces nasal blockage caused by seasonal allergens. - Sinusitis: helps clear nasal passages during acute sinus inflammation.

Adverse reactions are generally mild and localized to the nasal area.

Common Side Effects: - Burning sensation: mild irritation at the application site. - Sneezing: transient reflex after spray. - Nasal dryness: reduced moisture in the nasal mucosa. - Headache: mild tension type headache. - Epistaxis: occasional minor nosebleed. - Cough: brief irritation leading to cough.

Serious or Rare Side Effects: - Rebound congestion: worsening nasal blockage after prolonged use. - Severe allergic reaction: rash, itching, swelling or difficulty breathing. - Persistent nasal irritation: prolonged burning or ulceration. - Hypertension exacerbation: rare systemic effect in susceptible individuals. - Nasal septum perforation: extremely rare with misuse. - Anaphylaxis: life‑threatening allergic response.

Before using this nasal decongestant, consider the following safety measures: - Age restriction: only for children 2‑12 years as indicated. - Duration of use: limit to 3‑5 days to avoid rebound congestion. - Pre‑existing conditions: use cautiously in children with hypertension or heart disease. - Concurrent nasal medications: avoid using other topical decongestants simultaneously. - Allergy check: ensure no known hypersensitivity to xylometazoline or formulation excipients. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medications affecting vascular tone or nasal mucosa.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of excessive vasoconstriction. - Systemic alpha‑adrenergic agonists: additive blood pressure effects.

Moderate Interactions (Monitor Closely): - Nasal corticosteroids: may increase local irritation. - Antihistamines: potential for enhanced drying of nasal passages. - Anticoagulants: rare risk of prolonged epistaxis. - Decongestant tablets (pseudoephedrine): cumulative decongestant effect. - Herbal decongestants (e.g., ephedra): additive sympathomimetic activity.